title: Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung cancer.
authors.affiliation: Department of Medicine, Division of Oncology, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, California 94305, USA.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Riess
authors.forename: Joel W
authors.initials: JW
authors.lastname: Neal
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D000070818:Discoidin Domain Receptors; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D058990:Molecular Targeted Therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017468:Receptors, Fibroblast Growth Factor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D011975:Receptors, Mitogen / Q000037:antagonists & inhibitors* / Q000378:metabolism
chemical_list: D000970:Antineoplastic Agents; D017468:Receptors, Fibroblast Growth Factor; D011975:Receptors, Mitogen; D000070818:Discoidin Domain Receptors; D020794:Receptor Protein-Tyrosine Kinases